A citation-based method for searching scientific literature

Carol Aghajanian, Stephanie V Blank, Barbara A Goff, Patricia L Judson, Michael G Teneriello, Amreen Husain, Mika A Sovak, Jing Yi, Lawrence R Nycum. J Clin Oncol 2012
Times Cited: 781

James S Ferriss, James J Java, Michael A Bookman, Gini F Fleming, Bradley J Monk, Joan L Walker, Howard D Homesley, Jeffrey Fowler, Benjamin E Greer, Matthew P Boente, Robert A Burger. Gynecol Oncol 2015
Times Cited: 40

List of shared articles

Times cited

REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancer.
Katrin M Sjoquist, David Espinoza, Linda Mileshkin, Sumitra Ananda, Catherine Shannon, Sonia Yip, Jeffrey Goh, David Bowtell, Michelle Harrison, Michael L Friedlander. Gynecol Oncol 2021

Poly(ADP-ribose) polymerase inhibitors in combination with anti-angiogenic agents for the treatment of advanced ovarian cancer.
Olivia Le Saux, Hélène Vanacker, Fatma Guermazi, Mélodie Carbonnaux, Clémence Roméo, Louis Larrouquère, Olivier Trédan, Isabelle Ray-Coquard. Future Oncol 2021

Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).
Megan E Buechel, Danielle Enserro, Robert A Burger, Mark F Brady, Katrina Wade, Angeles Alvarez Secord, Andrew B Nixon, Seyedehnafiseh Mirniaharikandehei, Hong Liu, Bin Zheng,[...]. Gynecol Oncol 2021

Recent advancements of antiangiogenic combination therapies in ovarian cancer.
Daniel An, Susana Banerjee, Jung-Min Lee. Cancer Treat Rev 2021

Targeted therapy clinical trials in ovarian cancer: improved outcomes by gene mutation screening.
Quan Guo, Qing Yang, Jun Li, Guipeng Liu, Igor Nikoulin, Steve Jia. Anticancer Drugs 2020